Glenn Reicin - Net Worth and Insider Trading

Glenn Reicin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Glenn Reicin owns 3 companies in total, including Amplitude Healthcare Acquisition Corp (AMHCU) , Jasper Therapeutics Inc (JSPR) , and Sigilon Therapeutics Inc (SGTX) .

Click here to see the complete history of Glenn Reicin’s form 4 insider trades.

Insider Ownership Summary of Glenn Reicin

Ticker	Comapny	Transaction Date	Type of Owner
AMHCU	Amplitude Healthcare Acquisition Corp	2019-11-19	director
JSPR	Jasper Therapeutics Inc	2019-11-19	director
SGTX	Sigilon Therapeutics Inc	2020-12-03	Chief Financial Officer

Glenn Reicin Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Glenn Reicin Ownership Network

Ownership Network List of Glenn Reicin

No Data

Ownership Network Relation of Glenn Reicin

Glenn Reicin Owned Company Details

What does Amplitude Healthcare Acquisition Corp do?

Who are the key executives at Amplitude Healthcare Acquisition Corp?

Glenn Reicin is the director of Amplitude Healthcare Acquisition Corp. Other key executives at Amplitude Healthcare Acquisition Corp include 10 percent owner Glazer Capital, Llc , 10 percent owner Paul J Glazer , and President Vishal Kapoor .

Amplitude Healthcare Acquisition Corp (AMHCU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Amplitude Healthcare Acquisition Corp (AMHCU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Amplitude Healthcare Acquisition Corp (AMHCU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Amplitude Healthcare Acquisition Corp (AMHCU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Amplitude Healthcare Acquisition Corp Insider Transactions

No Available Data

What does Jasper Therapeutics Inc do?

Who are the key executives at Jasper Therapeutics Inc?

Glenn Reicin is the director of Jasper Therapeutics Inc. Other key executives at Jasper Therapeutics Inc include Chief Operating Officer Jeetinder Singh Mahal , 10 percent owner Carlyle Group Inc. , and other: See Footnote 1 Velan Capital Master Fund Lp .

Jasper Therapeutics Inc (JSPR) Insider Trades Summary

Over the past 18 months, Glenn Reicin made no insider transaction in Jasper Therapeutics Inc (JSPR). Other recent insider transactions involving Jasper Therapeutics Inc (JSPR) include a net sale of 11,700 shares made by Jeetinder Singh Mahal , a net purchase of 50,000 shares made by Thomas G Wiggans , and a net purchase of 350,000 shares made by Velan Capital Master Fund Lp .

In summary, during the past 3 months, insiders sold 900 shares of Jasper Therapeutics Inc (JSPR) in total and bought 0 shares, with a net sale of 900 shares. During the past 18 months, 4,397 shares of Jasper Therapeutics Inc (JSPR) were sold and 545,000 shares were bought by its insiders, resulting in a net purchase of 540,604 shares.

Jasper Therapeutics Inc (JSPR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Jasper Therapeutics Inc Insider Transactions

No Available Data

What does Sigilon Therapeutics Inc do?

Who are the key executives at Sigilon Therapeutics Inc?

Glenn Reicin is the Chief Financial Officer of Sigilon Therapeutics Inc. Other key executives at Sigilon Therapeutics Inc include 10 percent owner Lilly Eli & Co , 10 percent owner Shenandoah Acquisition Corp , and CHIEF OF STAFF AND CLO Matthew Paul Kowalsky .

Sigilon Therapeutics Inc (SGTX) Insider Trades Summary

Over the past 18 months, Glenn Reicin made no insider transaction in Sigilon Therapeutics Inc (SGTX). Other recent insider transactions involving Sigilon Therapeutics Inc (SGTX) include a net purchase of 1,718,493 shares made by Lilly Eli & Co ,

In summary, during the past 3 months, insiders sold 0 shares of Sigilon Therapeutics Inc (SGTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sigilon Therapeutics Inc (SGTX) were sold and 1,718,493 shares were bought by its insiders, resulting in a net purchase of 1,718,493 shares.

Sigilon Therapeutics Inc (SGTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sigilon Therapeutics Inc Insider Transactions

No Available Data

Glenn Reicin Mailing Address

Above is the net worth, insider trading, and ownership report for Glenn Reicin. You might contact Glenn Reicin via mailing address: 1177 Avenue Of The Americas, F140, New York Ny 10036.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.